Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Advertise | Contacts | Login 
  Users Online: 312 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

  Article Access Statistics

Year : 2021 | Volume:  11 | Issue Number:  1 | Page:  1-7

REVIEW ARTICLE

Firibastat, the first-in-class brain aminopeptidase a inhibitor, in the management of hypertension: A review of clinical trials
Alomar Sara Abdulrahman, Alghabban Sarah Ali, Alharbi Hadeel Abdulaziz, Almoqati Mehad Fahad, Alduraibi Yazid, Abu-Zaid Ahmed

Number of times this article was viewed 1380
Number of times this article has been printed  from the site 16
Number of times this article was emailed to others 0
Remarks given by readers [ Read ] 0

 

  Feedback 
  Subscribe 
 Back To Article

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal